11-113780466-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001101389.1(CLDN25):c.671C>T(p.Pro224Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000986 in 1,611,820 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001101389.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLDN25 | NM_001101389.1 | c.671C>T | p.Pro224Leu | missense_variant | 1/1 | ENST00000453129.3 | NP_001094859.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLDN25 | ENST00000453129.3 | c.671C>T | p.Pro224Leu | missense_variant | 1/1 | NM_001101389.1 | ENSP00000396304 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000578 AC: 88AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000109 AC: 27AN: 247770Hom.: 0 AF XY: 0.0000819 AC XY: 11AN XY: 134380
GnomAD4 exome AF: 0.0000486 AC: 71AN: 1459536Hom.: 1 Cov.: 31 AF XY: 0.0000358 AC XY: 26AN XY: 725712
GnomAD4 genome AF: 0.000578 AC: 88AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.000591 AC XY: 44AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2023 | The c.671C>T (p.P224L) alteration is located in exon 1 (coding exon 1) of the CLDN25 gene. This alteration results from a C to T substitution at nucleotide position 671, causing the proline (P) at amino acid position 224 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at